NT5E and breast carcinoma: In the breast cancer cell line 4T1, a time‐dependent increase in CD73 expression was observed, similar to the PC9 cells, and after 72 h exposure, the expression and enzymatic activity of CD73 increased by 3.6‐ and 2.3‐fold, respectively (P < 0.05, Fig. 1H,I).